Home › Head and Neck Squamous Cell Carcinoma › Arizona › Gilbert
Head and Neck Squamous Cell Carcinoma clinical trials in Gilbert, AZ
6 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Gilbert (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecruitingPhase 1
- Research Site, Gilbert
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Arizona Center for Cancer Care - Gilbert, Gilbert
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RecruitingPhase 2/3
- Banner MD Anderson Cancer Center, Gilbert
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
RecruitingPhase 3
- Arizona Center for Cancer Care - Gilbert, Gilbert
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- Banner MD Anderson Cancer Center, Gilbert
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Philadelphia, PA26 studies
- Arlington, VA26 studies
- Chicago, IL25 studies
- Atlanta, GA23 studies
- New Haven, CT22 studies
- San Antonio, TX22 studies
Other studies in Gilbert
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer9 studies
- Breast Cancer9 studies
- Cancer (all types)8 studies
- Lung Cancer8 studies
- Cardiovascular Disease6 studies
- Multiple Myeloma6 studies
- Metastatic Cancer6 studies
- Heart Failure6 studies
- Bladder Cancer6 studies
- Non-Hodgkin Lymphoma5 studies
- Diffuse Large B-Cell Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.